ASX:NYR

Nyrada Inc. Stock Insider Trading

Australian Securities Exchange > Healthcare > Biotechnology

$0.0590

+0.0020 (+3.51%)

At Close: Jun 28, 2024

Nyrada Inc. Stock Insider Power

Based on the 0 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 0 and sold 0 NYR.AX shares in the last 0 trades.

Historical Insider Trades

There is currently no insider trading information for this ticker.

However, we invite you to learn more about this term and how to use this knowledge to benefit your trading strategy:

Sorry! Image not available at this moment

About Nyrada Inc.

Nyrada Inc., a pre-clinical stage drug development company, engages in the development of small molecule drugs for cardiovascular, neurodegenerative, and chronic inflammatory diseases. Its products in the drug development stage include PCSK9 inhibitor for the treatment of high blood LDL-cholesterol levels in patients poorly responsive to or unable to take statin drugs; NYR-BI01, a neuroprotectant drug, to reduce the disability in patients with is... NYR.AX Profile

Golden Star

Ticker	Date	Change	Price
FFIV	Jun 26	1.75%	$169.26
VIGI	Jun 26	0.694%	$80.72
EHC	Jun 25	1.08%	$84.87
SNAP	Jun 24	6.00%	$15.67
EVBG	Jun 21	0.662%	$34.76
DDOG	Jun 21	10.31%	$117.57
SRE	Jun 20	0.768%	$75.48
PEG	Jun 20	0.163%	$73.58
DOC	Jun 20	1.14%	$19.38
EPD	Jun 18	2.40%	$28.30

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In